Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. BriaCell Therapeutics Corp’s current trading price is -92.65% away from its 52-week high, while its distance from the 52-week low is -1.07%. The stock’s price range over this period has fluctuated between $4.85 and $65.25. The company, operating within the financial sector, had a trading volume of approximately 13.25 million for the day, which was noticeably higher than the average daily share volume of 94290.0 over the last 3 months.
In terms of market performance, BriaCell Therapeutics Corp had a fairly uneven. The highest value for the stock in the past year was $65.25 on 02/06/24, and the lowest value was recorded at $4.85 on 02/03/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
BriaCell Therapeutics Corp (BCTX) has experienced a quarterly decline of -58.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 14.15M and boasts a workforce of 18 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.49, with a change in price of -5.31. Similarly, BriaCell Therapeutics Corp recorded 394,205 in trading volume during the last 100 days, posting a change of -52.06%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BCTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
BCTX Stock Stochastic Average
Today, BriaCell Therapeutics Corp’s raw stochastic average for the past 50 days stands at 1.50%, indicating a decline from the raw stochastic average of the last 20 days, which was 4.24%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 5.83% and 8.93% respectively.
BCTX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded a decrease of -43.38%. However, over the last six months, the performance has been stronger by -55.91%. The price of BCTX decreased -43.38% over the last 30 days. And in the last five days, it has fallen by -17.28%.
